Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 10 Key Players companies in Insulin resistance
by Highest Patent Value in the France in 2019

The Insulin resistance top 10 is Discovery PatSnap’ annual ranking of the top 10 Highest Patent Value Insulin resistance Key Players in the France. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2019, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
A condition where the body does not respond to insulin.
#
Company Name
Region
Tech Topics
Total
1
Ipsen Pharma SAS
Medicine,Neuroscience,Biopharmaceutical,
...[+1]
Avg patent value: 7.73 M
2
Valbiotis SA
Nutrition,Steatohepatitis,Nonalcoholic fatty liver disease,
...[+2]
Avg patent value: 7.59 M
3
Genfit SA
Nuclear receptor,Health care,Drug discovery,
...[+2]
Avg patent value: 5.77 M
4
Galderma Research & Development SNC
Medicine
Avg patent value: 3.87 M
5
Poxel SA
Medicine,Steatohepatitis,Biomedicine,
...[+2]
Avg patent value: 3.60 M
6
Pharnext SA
Neuroscience,Health care,Drug,
...[+2]
Avg patent value: 3.27 M
7
Générale Biscuit SAS
Food industry,Snack foods
Avg patent value: 2.71 M
8
Laboratoires Expanscience SA
Medicine,Health care,Glucosamine,
...[+2]
Avg patent value: 1.97 M
9
Institut National de la Santé et de la Recherche Médicale
Public health,Genomics,Antisense therapy,
...[+2]
Avg patent value: 1.86 M
10
Centre International pour la Recherche Agronomique
Social science,Sustainable development
Avg patent value: 1.29 M
Page generation time: Jul 20 2025